Question 1

Is Dabigatran Etexilate currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Dabigatran Etexilate has 6 active shortage notices across 3 countries (United States, Canada, Belgium). Status is refreshed daily from official regulatory sources.

Question 2

Why is Dabigatran Etexilate in shortage?

Accepted Answer

Regulators attribute the current Dabigatran Etexilate shortages to manufacturing problems, causes not stated by the regulator, regulatory action. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Dabigatran Etexilate shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 12 Jun 2026 to 26 Oct 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Dabigatran Etexilate shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
United States	high	2	14 Mar 2023	—	FDA MedWatch
Canada	medium

Dabigatran Etexilate shortage status

Where Dabigatran Etexilate is in shortage

Why Dabigatran Etexilate is in shortage

Frequently asked questions

Related medicines

Get alerted when Dabigatran Etexilate status changes